輸入代號或公司名稱後按 Enter
4192

杏國

-0.65 (-3.44%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
18.255成交張數本益比2.93股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.38-1.33-0.13-214.5%-5.96%-19.31%
2026Q1-0.37-1.28-0.13-211.9%-5.43%-17.59%
2025Q4-0.35-1.30-0.12-167.8%-4.91%-16.94%
2025Q3-0.23-1.32-0.08-124.3%-3.07%-16.29%
2025Q2-0.33-1.50-0.12-149.5%-4.28%-17.79%
2025Q1-0.39-1.55-0.14-253.6%-4.75%-17.35%
2024Q4-0.37-126.2%-1.54-0.13-197.8%-4.30%-16.66%
2024Q3-0.410.24-0.14-271.9%-4.50%0.15%
2024Q2-0.38-0.34-0.13-190.5%-3.99%-5.60%
2024Q1-0.38-1.36-0.13-305.5%-3.79%-9.65%
2023Q41.41-1.190.42673.6%15.86%-12.59%
2023Q3-0.99-3.30-0.29-509.3%-16.11%-64.90%
2023Q2-1.40-2.57-0.26-583.1%-12.52%-58.06%
2023Q1-0.21-1.45-0.24-646.0%-10.13%-54.28%
2022Q4-0.70-1.61-0.82-1604.6%-28.23%-54.53%
2022Q3-0.26-1.60-0.31-682.2%-8.84%-43.48%
2022Q2-0.28-3.22-0.34-1164.6%-8.87%-67.42%
2022Q1-0.36-3.69-0.42-1260.1%-10.01%-69.13%
2021Q4-0.69-3.96-0.80-2792.2%-16.47%-91.40%
2021Q3-1.88-4.22-2.19-14773.8%-34.14%-80.40%
2021Q2-0.76-3.28-0.88-6915.7%-11.11%-47.81%
2021Q1-0.64-3.54-0.72-5450.5%-10.23%-56.44%
2020Q4-0.94-3.76-1.03-1812.5%-16.73%-68.04%
2020Q3-0.94-3.95-1.02-2593.8%-14.16%-58.05%
2020Q2-1.02-4.14-1.10-6618.7%-16.84%-64.43%
2020Q1-0.85-4.56-0.85-4060.1%-14.82%-72.87%
2019Q4-1.14-4.45-1.12-5280.8%-16.59%-61.97%
2019Q3-1.13-4.42-1.11-5433.3%-17.55%-49.25%
2019Q2-1.44-4.30-1.22-5238.3%-20.84%-64.57%
2019Q1-0.75-3.83-0.64-981.6%-9.36%-45.89%
2018Q4-1.11-3.81-0.92-4784.9%-11.95%-41.21%
2018Q3-1.00-3.65-0.81-4026.7%-11.33%-33.12%
2018Q2-0.97-3.55-0.69-3551.6%-10.87%-35.50%
2018Q1-0.73-3.46-0.52-2845.8%-7.40%-31.28%
2017Q4-0.95-610.7%-3.62-0.68-3405.6%-8.95%-30.59%
2017Q3-0.90-2.48-0.64-3140.4%-7.90%-20.75%
2017Q2-0.88-2.48-0.63-2764.4%-7.28%-23.45%
2017Q1-0.88-2.63-0.63-3442.9%-6.77%-21.36%
2016Q40.19-2.570.04218.3%0.44%
2016Q3-0.90-0.55-3400.1%-6.60%